Spanish version of a scale for the assessment of mania: Validity and reliability of the Young Mania Rating Scale;Versión espanáola de una escala de evaluación de la manía: Validez y fiabilidad de la Escala de Young

Medicina Clinica

Volumn 119, Issue 10, 2002, Pages 366-371

  Colom, Francesc ^a   Vieta, Eduard ^a   Martínez Arán, Anabel ^a   Garcia Garcia, Margarida ^a,b   Reinares, María ^a,b   Torrent, Carla ^a,b   Goikolea, José Manuel ^a,b   Banös, Sebastiá ^a   Salamero, Manel ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Assessment; Bipolar disorder; Mania; Validation

Indexed keywords

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEASIBILITY STUDY; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MANIA; MEDICAL EDUCATION; PHYSICIAN; PSYCHOLOGIC ASSESSMENT; RATING SCALE; RELIABILITY; SAMPLING; SENSITIVITY ANALYSIS; SPAIN; STANDARD; VALIDATION PROCESS; CLINICAL TRIAL; MULTICENTER STUDY; PSYCHOLOGICAL RATING SCALE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

BIPOLAR DISORDER; HUMANS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0037190284     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)73419-2     Document Type: Article

References (12)

1. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiat 1978; 133:429-35.
2. Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KNR, Daniel DG, et al. Olanzapine vs. placebo in the treatment of acute mania. Am J Psychiat 1999;156:702-9.
3. Tohen M, Jacobs TG, Grundy SL, Banov MC, McElroy SL, Janicack PG, et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000;57:841-9.
4. Tohen M, Chengappa KNR, Suppes T, Zarate CA, Calabrese JR, Bowden CL, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiat 2002;59:62-9.
5. Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, et al, for the GSRAD. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a six-month, multicenter, open study. J Clin Psychiat 2001;62:818-25.
6. Vieta E, Gastó C, Colom F, Reinares M, Martínez-Arán A, Benabarre A, et al. The role of risperidone in bipolar II: an open six-month study. J Affect Disord 2001;67:213-9.
7. Vieta E, Parramon G, Padrell E, Nieto E, Martínez-Arán A, Corbella B, et al. Quetiapine in the treatment of rapid cycling bipolar disorder Bipolar Disorders [en prensa].
8. Beigel A, Murphy DL. Assessing clinical characteristics of the manic state. Am J Psychiat 1971; 128:688-94.
9. Blackburn JM, London JB, Ashworth CM. A new scale for measuring mania. Psychol Med 1977; 7:453-8.
10. Petterson V, Fyro B, Sedval G. A new scale for the longitudinal rating of manic scales. Acta Psych Scand 1973;49:248-56.
11. Livianos L, Rojo L, Guillem JL, Villavicencio D, Pino A, Mora R, et al. Adaptación de la Escala de la Valoración de la Mania por Clinicos (EV-MAC). Actas Esp Psiquiat 2000;28:169-77.
12. Vieta E, Torrent C, Martínez-Arán A, Colom F, Reinares M, Benabarre A, et al. Una escala sencilla de evaluación del curso del trastorno bipolar: la CGI-BP-M Actas Psiq Esp [en prensa].